News

Promising research on Usher syndrome

Erwin van Wijk, researcher at Hearing and Genes, wants to contribute to making Usher syndrome treatable. The results so far are better than he had dared to hope.

Surprisingly dominant cause underlying type I congenital defect of glycosylation

Alex Garanto, Melissa Bärenfänger, Mirian Janssen, and Dirk Lefeber published a new study, identifying a surprisingly dominant genetic cause underlying type I congenital defect of glycosylation with neuromusculoskeletal phenotypes.

Treatment of brain diseases at risk if neuroscientists can no longer conduct their research

In order to treat brain diseases such as depression, Alzheimer's or ADHD, more research into the brain is needed.

Retina-on-chip modeling and treating eye diseases in a dish

Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.

Innovative therapy developed for the future treatment of hereditary (deaf)blindness

Researchers from the department of Otorhinolaryngology, headed by Erwin van Wijk, developed a novel therapeutic strategy to halt the progression or to prevent vision loss in patients as a consequence of USH2A exon 13 mutations.

Foundation Fighting Blindness Awards 1.4 million dollars for Rob Collin and Carel Hoyng

Two researchers from the Radboudumc have received a prestigious award from the Translational Research Acceleration Program of the Foundation Fighting Blindness USA.

Rob Collin appointed Professor of Molecular therapy for inherited retinal diseases

Effective 16 January 2021, molecular geneticist Rob Collin has been appointed Professor of 'Molecular Therapy for Inherited Retinal Diseases' at Radboudumc Radboud University.

Novartis grant received for retinal dystrophy gene sequencing

Novartis approved a 600K euro grant proposal from Frans Cremers, Susanne Roosing and Alexander Hoischen

New genetic cause for vision impairment and blindness discovered

After thirty years of research, the genetic defect that causes the eye disease retinitis pigmentosa type 17 (RP17) has finally been discovered.

Finally, an explanation for hearing loss in twelve Dutch families

The culprit is a genetic abnormality, a discovery that immediately makes it one of the most common causes of hereditary hearing loss in the Netherlands.

Towards an AI diagnosis like the doctor's

How can we make ‘lazy’ artificial intelligence more transparent and relevant to the clinic?

Gene controls the formation of photosensitive disks in retinal cells

Researchers have unraveled a molecular mechanism that regulates the build-up of the photosensitive segments in the cones and rods in the retina. A protein PCARE, controls this process. These new insights, published in PNAS USA, could make a significant contribution to new therapies for eye diseases.

Radboudumc and LUMC launch center for RNA therapy for ultrarare diseases

The aim of this new virtual centre is to develop customised RNA therapies for patients with rare genetic conditions. Several DCMN researchers and medical specialists are involved in DCRT.

DCMN big data mini-symposium held on 31 January

On 31 January, DCMN researchers and collaborators gathered to talk about big data, as a means to work towards Open Science.

Study expected to improve prediction of the results of cochlear implants

Emmanuel Mylanus and Wendy Huinck of the ENT department, DCMN, have received a Horizon 2020 grant of €1 million for the MOSAICS project.

A band aid to prevent blindness a solution in the fight against Stargardt disease

You cut your finger? Patch it up with a band aid and let the healing begin. How convenient would it be if this would work in an eye. If you can cure blinding eye diseases with a band aid, or at least slow them down.

Awardees DCMN Junior Researcher round 2019

DCMN launched a call call for Radboudumc junior researcher (PhD) positions. This year 6 positions have awarded.

Successful teamwork between Neurology and Human Genetics leads to identification of two new ataxia genes

Thanks to close cooperation between Bart van de Warrenburg (Neurology) and Erik-Jan Kamsteeg (Humans Genetics) two new genes involved in movement disorders were identified. The genes are relevant for autosomal recessive cerebellar ataxia.

RP Fighting Blindness Grant for Rob Collin and Frans Cremers

Rob Collin and Frans Cremers have been awarded a £ 120,000 grant from the RP Fighting Blindness society in the UK.

Save the date for Radboud New Frontiers 2018: Betere zorg, netwerkzorg?

After standard care, standardized care, and personalized care, network care will be care 4.0. But how exactly do you do that? Should we create new structures for it or is it just a matter of trust and ability to step back?

Save the date for Radboud New Frontiers 2018: Big data, better healthcare?

How is big data influencing healthcare and healthcare research? How will it help us and what are the limitations? The first day of the 12th edition of the Radboud New Frontiers symposium, on 1 November 2018, will give you all the answers (and raises new questions).

Register now for RIMLS PhD Retreat

Tomorrow 2 February is the last chance for the early bird registration for the RIMLS PhD retreat 2018.

ZonMW rewards groundbreaking ideas DCMN researcher Erik de Vrieze

This year ZonMw granted Erik de Vrieze an Off Road subsidy.

Sensory Disorders Talent Award 2017

Sensory Disorders

Fighting Blindness' to fund vision research

ZonMW Top grant to delay retinal degeneration